HLB Reapply for Liver Cancer Drug Approval from FDA
HLB logo. On 16 May this year, the FDA issued a Complete Response Letter (CRL) requesting...
HLB
HLB Fails to Receive US FDA Approval for Rivoceranib Liver Cancer Treatment
The logo of HLB HLB has failed to secure approval from the U.S. Food and Drug...
